Table 1.
Clinical characteristics by DM status in pancreatic cancer patients
| Variables | DM vs Non-DM | |||||
|---|---|---|---|---|---|---|
| Total (n = 131) | DM (n = 58) | Non-DM (n = 73) | p value | t-value | ||
| Sex | Male | 76 (58.0) | 36 (62.1) | 40 (54.8) | 0.402 | |
| Female | 55 (42.0) | 22 (37.9) | 33 (45.2) | |||
| Site of Primary Tumour | Head | 78 (59.5) | 38 (65.5) | 40 (54.8) | 0.214 | |
| Body | 24 (18.3) | 12 (20.7) | 12 (16.4) | 0.532 | ||
| Tail | 12 (9.2) | 5 (8.6) | 7 (9.6) | 0.750 | ||
| Unknown | 17 (13.0) | 3 (5.2) | 14 (19.2) | 0.018 | ||
| Stage at PC Diagnosis | Stage 1 | 5 (3.8) | 3 (5.2) | 2 (2.7) | 0.470 | |
| Stage 2 | 29 (22.1) | 15 (25.9) | 14 (19.2) | 0.360 | ||
| Stage 3 | 32 (24.4) | 13 (22.4) | 19 (26.0) | 0.633 | ||
| Stage 4 | 60 (45.8) | 26 (44.8) | 34 (46.6) | 0.842 | ||
| Unknown | 5 (3.8) | 1 (1.7) | 4 (5.5) | 0.265 | ||
| Surgery | Yes | 37 (28.2) | 11 (19.0) | 26 (35.6) | 0.035 | |
| No | 94 (71.8) | 47 (81.0) | 47 (64.4) | |||
| Chemotherapy | Yes | 94 (71.8) | 42 (72.4) | 52 (71.2) | 0.881 | |
| No | 37 (28.2) | 16 (27.6) | 21 (28.8) | |||
| Radiotherapy | Yes | 30 (22.9) | 14 (24.1) | 16 (21.9) | 0.764 | |
| No | 101 (77.1) | 44 (75.9) | 57 (78.1) | |||
| Mean Age (years) | 68.2 | 68.5 | 68.0 | 0.379 | 0.308 | |